In 2023, Kangbeijing further expanded its plasma production line, forming a complete product system ranging from medical use to commercial and civil use.
Currently, in response to different scenarios and purification and disinfection requirements, Kangbeijing has established three air purification and disinfection product systems, namely Aikang, Aibei, and Aijing. It can provide customers with full-scenario and personalized healthy air solutions, and has occupied a place in the high-end air purification and disinfection market.
Adhering to the business philosophy of "Technological Innovation and Pioneering Spirit", the company has deeply focused on the improvement and upgrading of plasma manufacturing equipment technology, and continuously increased its investment in science and technology. In 2023, Kangbeijing obtained the Certificate of New Industrial Products in Zhejiang Province and a number of national invention patents. It has accumulated a number of core technologies with independent intellectual property rights in the field of plasma purification and disinfection, injecting strong impetus into the development of the enterprise. In 2024, the company was rated as a "Science and Technology-based Small and Medium-sized Enterprise" in Zhejiang Province.
According to the testing by third-party authoritative institutions, the company's products have the ability to quickly and efficiently inactivate and remove bacteria, viruses, and harmful gases such as TVOC, and the product parameters are far higher than the relevant international standards.
One of the most crucial and core technologies in the process of plasma technology transformation and application is the production technology of plasma generators. Among the plasma air purification and disinfection equipment advertised on the market, some brands actually have a high-voltage electrostatic grid as their internal structure and do not have the function of generating plasma. Some brands are equipped with plasma devices using single-electrode corona discharge technology, which belongs to the primary plasma generator, and the generation density and activity of plasma cannot meet the needs of medical application development.
The Kangbeijing plasma generator adopts the Dielectric Barrier Discharge (DBD) technology, which is currently the mainstream plasma generation technology in the field of plasma medicine. Based on DBD, a single-pole plasma jet generator and a DBD plasma jet generator have been successively developed, which can generate low-temperature atmospheric plasma with high stability, high activity, and a large area, meeting the conditions for further in-depth development in the medical field.